Call Free, Anytime, 24/7:
(303) 222-2222
(970) 222-2222
(719) 888-8888

Study Done by Drug Companies Discredited

The American Association for Justice Discredits Drug Companies “Study”

The American Association for Justice (AAJ) recently released a statement exposing a current study by drug companies that was done to discredit personal injury attorneys. AAJ stated that the study was faulty and poorly researched by basing their facts entirely on Google searches. AAJ represents lawyers who have the interest of injured individuals at hand and continues to lead their Fight for Justice Campaign which fights “studies” like these by making sure people are receiving accurate and useful information from journalists.

The false report was released by the Center for Medicine in the Public Interest (CMPI) and highlighted by the American Tort Reform Association (ATRA). The report criticized personal injury attorneys as well as declaring that people who look online for medical advice often receive unreliable information from class action and litigation sites. The ATRA is now calling for congressional failure to notice hearings and for all State Bar associations to require lawyers to identify themselves on websites they sponsor.

As a result, AAJ quickly fired back that the study was “laughable at best” and exclaimed that “it’s no surprise that the big drugmakers are trying to buy studies to avoid responsibility for their drugs that have harmed people,” stated AAJ President Kathleen Flynn Peterson.

AAJ has a research team that follows CMPI and ATRA along with various other organizations that make baseless claims in these so-called studies.

More information about this topic can be found at

Founding partner, Kyle Bachus, is a firm advocator for consumers and their rights and holds the elected seat representing the state of Colorado on the Board of Governors for the American Association for Justice.

Tell Us What Happened

Get your free case evaluation.

Contact Us

main case intake form for use site wide
  • This field is for validation purposes and should be left unchanged.